Centessa Pharmaceuticals plc (CNTA) - Quarterly Income Statement

Home
CNTA
Financials

13.72 (USD) • At close April 29, 2025

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2024 Q4	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1
Revenue Numbers are in millions	0	0	0	0	6.913	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost of Revenue Numbers are in millions	0	0	0.236	0.24	0.248	0.237	0.238	0.09	0.036	0.035	0.032	0.028	0.012	0.013	0	0.002	0	0	0	0
Gross Profit Numbers are in millions	0	0	-0.236	-0.24	6.664	-0.237	-0.238	-0.09	-0.036	-0.035	-0.032	-0.028	-0.012	-0.013	0	-0.002	0	0	0	0
Gross Profit Ratio Numbers are in millions	0	0	0	0	0.964	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Reseach & Development Expenses Numbers are in millions	60.874	33.903	32.815	22.639	29.975	28.19	33.673	32.826	27.835	36.744	53.651	36.853	41.534	25.85	18.134	10.779	0.994	2.574	1.871	3.333
General & Administrative Expenses Numbers are in millions	13.706	12.502	11.165	13.438	12.315	12.019	13.346	16.051	13.768	12.284	14.763	14.385	12.988	12.464	11.841	5.716	0.308	0.193	0.258	0.383
Selling & Marketing Expenses Numbers are in millions	0	0	0	-0.248	-0.141	0	0	0	0	0	0	0	0	0	0	2.523	0	0	0	0
SG&A Numbers are in millions	13.706	12.502	11.165	13.19	12.174	12.019	13.346	16.051	13.768	12.284	14.763	14.385	12.988	12.464	11.841	8.239	0.308	0.193	0.258	0.383
Other Expenses Numbers are in millions	0	0	0	-1.537	-0.878	-1.677	-1.527	-1.346	-0.07	-3.143	5.359	0.196	0.235	-1.906	-0.191	0	0	0	0	0
Operating Expenses Numbers are in millions	74.58	46.405	43.98	35.83	42.148	40.209	47.019	48.877	41.603	49.028	68.414	51.238	54.522	38.314	29.975	19.019	3.184	2.038	2.139	2.925
Operating Income Numbers are in millions	-74.58	-46.405	-43.98	-36.069	-35.484	-40.209	-47.019	-48.877	-41.603	-49.028	-68.414	-53.218	-58.292	-38.314	-41.287	-19.021	-3.005	-2.116	-2.129	-3.192
Operating Income Ratio Numbers are in millions	0	0	0	0	-5.133	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Other Income Expenses Net Numbers are in millions	-35.699	4.447	0.869	-1.475	-0.515	-1.265	-1.918	-1.16	-2.234	-4.988	3.731	-1.2	-2.368	-1.841	-0.164	-221.267	-0.281	-0.022	-0.099	0.181
Income Before Tax Numbers are in millions	-110.279	-41.958	-43.111	-37.544	-36.003	-41.474	-48.937	-50.037	-43.837	-54.016	-64.683	-54.418	-60.66	-40.155	-41.451	-240.288	-3.286	-2.138	-2.228	-3.011
Income Before Tax Ratio Numbers are in millions	0	0	0	0	-5.208	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Income Tax Expense Numbers are in millions	1.05	0.608	0.705	0.481	1.154	-2.826	-24.051	0.677	-0.664	-0.141	-0.022	0.08	0.114	-0.065	-11.339	0	0	-0.022	-0.099	0.181
Net Income Numbers are in millions	-111.329	-42.566	-43.816	-38.024	-37.157	-38.648	-24.886	-50.714	-43.173	-53.875	-64.661	-54.498	-60.774	-40.155	-41.451	-240.288	-3.286	-2.138	-2.228	-3.011
Net Income Ratio Numbers are in millions	0	0	0	0	-5.375	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS Numbers are in millions	-0.84	-0.37	-0.4	-0.38	-0.38	-0.4	-0.26	-0.53	-0.46	-0.57	-0.69	-0.6	-0.68	-0.45	-0.65	-2.75	-0.22	-0.015	0	0
EPS Diluted Numbers are in millions	-0.84	-0.37	-0.4	-0.38	-0.38	-0.4	-0.26	-0.53	-0.46	-0.57	-0.69	-0.6	-0.68	-0.45	-0.65	-2.75	-0.22	-0.015	0	0
EBITDA Numbers are in millions	-107.57	-39.165	-40.395	-34.776	-33.163	-38.47	-46.399	-48.035	-41.949	-51.692	-62.475	-52.691	-58.212	-39.962	-41.287	-240.237	-3.004	-0.022	-0.099	0.181
EBITDA Ratio Numbers are in millions	0	0	0	0	-4.797	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Centessa Pharmaceuticals plc

NASDAQ:CNTA Add to watchlist

NASDAQ:CNTA